Displaying drugs 51 - 64 of 64 in total
Ipragliflozin
Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2.
Investigational
Matched Description: … Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2. …
Matched Categories: … Alimentary Tract and Metabolism ... Sodium-Glucose Transporter 2 Inhibitors ... Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors …
Matched Categories: … Alimentary Tract and Metabolism ... Sodium-Glucose Transporter 2 Inhibitors ... Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors …
Paramethasone
A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than hydrocortisone with supplementary fludrocortisone. (From Martindale, The Extra Pharmacopoeia,...
Experimental
Matched Description: … in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining …
Matched Categories: … Sex Hormones and Insulins ... Hormones, Hormone Substitutes, and Hormone Antagonists …
Matched Categories: … Sex Hormones and Insulins ... Hormones, Hormone Substitutes, and Hormone Antagonists …
Saprisartan
Saprisartan is an AT1 receptor antagonist. It is based on medications of losartan's prototypical chemical structure. The mode of (functional) AT1 receptor antagonism has been characterized as insurmountable/noncompetitive for saprisartan. It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism .
Experimental
Acifluorfen
Acifluorfen is a protoporphyrinogen oxidase inhibitor.
Experimental
Matched Salts name: … Acifluorfen sodium …
Alisertib
Alisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer.
Investigational
Matched Salts name: … Alisertib sodium …
Refametinib
Investigational
Vanoxerine
Vanoxerine is a highly selective dopamine transporter antagonist. It was synthesized in the late 1970s and developed as a potential treatment for depression. Vanoxerine was later evaluated as a potential treatment for cocaine addiction due to its ability to block dopamine reuptake with a slower dissociation rate than cocaine. Although...
Investigational
Matched Description: … It was synthesized in the late 1970s and developed as a potential treatment for depression. ... [A248555] Vanoxerine is an investigational drug and has not been approved for therapeutic use. ... [A248585] More recently, vanoxerine was tested as a potential anti-arrhythmic and anti-atrial fibrillatory …
T-900607
T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer.
Investigational
Matched Description: … T900607 has been used in trials studying the treatment of Liver Cancer and Gastric Cancer. …
Matched Salts name: … T 900607 Sodium …
Matched Salts name: … T 900607 Sodium …
Flomoxef
Flomoxef has been used in trials studying the treatment of Urinary Tract Infection.
Investigational
Matched Salts name: … Flomoxef Sodium …
Oglemilast
Oglemilast has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.
Investigational
Matched Salts name: … Oglemilast Sodium …
Danoprevir
Danoprevir has been used in trials studying the treatment of Hepatitis C, Chronic.
Investigational
Matched Salts name: … Danoprevir sodium …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Categories: … Amino Acids, Peptides, and Proteins …
MLN8054
MLN8054 has been used in trials studying the treatment of Colon Neoplasm, Breast Neoplasm, Bladder Neoplasm, Pancreatic Neoplasm, and Advanced Malignancies.
Investigational
Matched Description: … trials studying the treatment of Colon Neoplasm, Breast Neoplasm, Bladder Neoplasm, Pancreatic Neoplasm, and …
Matched Salts name: … MLN8054 sodium …
Matched Salts name: … MLN8054 sodium …
Displaying drugs 51 - 64 of 64 in total